DOID:120: Difference between revisions

Latest revision as of 16:48, 12 September 2014

female reproductive organ cancer

Namespace:

FANTOM

Definition:

"A reproductive organ cancer that is manifested in the female genitals. This includes organs such as the ovaries, fallopian tubes, uterus, cervix, vagina and vulva." [url:http://en.wikipedia.org/wiki/Template:Female_genital_neoplasia, url:http://www.wrongdiagnosis.com/g/genital_system_cancer/intro.htm]

Xrefs:

links:

MSH:D005833
NCI:C3053
SNOMEDCT_2010_1_31:126907002
SNOMEDCT_2010_1_31:188207007
UMLS_CUI:C0017416
UMLS_CUI:C0153585

UMLS_CUI:C0699889

Synonyms:

"female reproductive cancer" EXACT []
"malignant Gynecologic tumor" EXACT [NCI2004_11_17:C4913]
"malignant neoplasm of female genital organ" EXACT []

Alt_id:

DOID:1244
DOID:1281

Ontology association Each term has an is_a parent in the Disease Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to DISEASE ontologies. link to ontology dataset data

Parents

is_a:	DOID:193(reproductive organ cancer)

Children

is a:	DOID:2021 (placenta cancer),DOID:2394 (ovarian cancer),DOID:3001 (female reproductive endometrioid cancer),DOID:363 (uterine cancer),DOID:4362 (cervical cancer)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples

Human (Homo sapiens)

10431-106D8 (epidermoid carcinoma cell line:Ca Ski)
10448-106F7 (endometrial stromal sarcoma cell line:OMC-9)
10497-107C2 (endometrial carcinoma cell line:OMC-2)
10530-107F8
10552-107I3 (cervical cancer cell line:D98-AH2)
10553-107I4 (cervical cancer cell line:ME-180)
10589-108D4 (argyrophil small cell carcinoma cell line:TC-YIK)
10598-108E4
10623-108H2
10636-108I6 (clear cell carcinoma cell line:TEN)

... further results Mouse (Mus musculus)

10431-106D8 (epidermoid carcinoma cell line:Ca Ski)
10448-106F7 (endometrial stromal sarcoma cell line:OMC-9)
10497-107C2 (endometrial carcinoma cell line:OMC-2)
10530-107F8
10552-107I3 (cervical cancer cell line:D98-AH2)
10553-107I4 (cervical cancer cell line:ME-180)
10589-108D4 (argyrophil small cell carcinoma cell line:TC-YIK)
10598-108E4
10623-108H2
10636-108I6 (clear cell carcinoma cell line:TEN)

... further results

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with DOID:120 (female reproductive organ cancer), sorted by p-values Analyst: Hideya Kawaji link to source dataset human : data mouse : data

Show entries

Search:

P-value	FFCP	Short description
3.65e-39	FFCP PHASE2:Hg19::chr5:136482422..136482426,+	p@chr5:136482422..136482426, +
3.65e-39	FFCP PHASE1:Hg19::chr5:136482422..136482426,+	p@chr5:136482422..136482426, +
2.16e-37	FFCP PHASE1:Hg19::chr4:90332316..90332323,+	p@chr4:90332316..90332323, +
2.16e-37	FFCP PHASE2:Hg19::chr4:90332316..90332323,+	p@chr4:90332316..90332323, +
2.6e-36	FFCP PHASE1:Hg19::chr5:81654563..81654582,+	p@chr5:81654563..81654582, +
2.6e-36	FFCP PHASE2:Hg19::chr5:81654563..81654582,+	p@chr5:81654563..81654582, +
9.43e-34	FFCP PHASE2:Hg19::chr16:88278862..88278869,-	p@chr16:88278862..88278869, -
9.43e-34	FFCP PHASE1:Hg19::chr16:88278862..88278869,-	p@chr16:88278862..88278869, -
1.17e-32	FFCP PHASE1:Hg19::chr4:118247051..118247056,+	p@chr4:118247051..118247056, +
1.17e-32	FFCP PHASE2:Hg19::chr4:118247051..118247056,+	p@chr4:118247051..118247056, +
2.36e-32	FFCP PHASE2:Hg19::chr1:9262795..9262800,-	p3@ENST00000437157
2.36e-32	FFCP PHASE1:Hg19::chr1:9262795..9262800,-	p3@ENST00000437157
2.85e-32	FFCP PHASE2:Hg19::chr2:113981834..113981850,-	p@chr2:113981834..113981850, -
2.85e-32	FFCP PHASE1:Hg19::chr2:113981834..113981850,-	p@chr2:113981834..113981850, -
7.1e-31	FFCP PHASE2:Hg19::chr1:98206661..98206672,-	p@chr1:98206661..98206672, -
7.1e-31	FFCP PHASE1:Hg19::chr1:98206661..98206672,-	p@chr1:98206661..98206672, -
7.55e-31	FFCP PHASE2:Hg19::chr6:75178505..75178516,+	p@chr6:75178505..75178516, +
7.55e-31	FFCP PHASE1:Hg19::chr6:75178505..75178516,+	p@chr6:75178505..75178516, +
1.02e-30	FFCP PHASE2:Hg19::chr3:45152138..45152151,-	p5@CDCP1
1.02e-30	FFCP PHASE1:Hg19::chr3:45152138..45152151,-	p5@CDCP1
5.44e-30	FFCP PHASE2:Hg19::chr18:25694851..25694855,-	p@chr18:25694851..25694855, -
5.44e-30	FFCP PHASE1:Hg19::chr18:25694851..25694855,-	p@chr18:25694851..25694855, -
2.95e-29	FFCP PHASE2:Hg19::chr5:81654586..81654599,+	p@chr5:81654586..81654599, +
2.95e-29	FFCP PHASE1:Hg19::chr5:81654586..81654599,+	p@chr5:81654586..81654599, +
6.21e-29	FFCP PHASE2:Hg19::chr14:62024238..62024249,+	p@chr14:62024238..62024249, +
6.21e-29	FFCP PHASE1:Hg19::chr14:62024238..62024249,+	p@chr14:62024238..62024249, +
2.34e-28	FFCP PHASE2:Hg19::chr9:6257179..6257191,+	p@chr9:6257179..6257191, +
2.34e-28	FFCP PHASE1:Hg19::chr9:6257179..6257191,+	p@chr9:6257179..6257191, +
8.67e-28	FFCP PHASE1:Hg19::chr18:53169326..53169330,-	p@chr18:53169326..53169330, -
8.67e-28	FFCP PHASE2:Hg19::chr18:53169326..53169330,-	p@chr18:53169326..53169330, -
9.15e-27	FFCP PHASE2:Hg19::chr4:167068286..167068320,+	p@chr4:167068286..167068320, +
9.15e-27	FFCP PHASE1:Hg19::chr4:167068286..167068320,+	p@chr4:167068286..167068320, +
1.8e-26	FFCP PHASE2:Hg19::chr1:222079924..222079927,-	p@chr1:222079924..222079927, -
1.8e-26	FFCP PHASE1:Hg19::chr1:222079924..222079927,-	p@chr1:222079924..222079927, -
3.38e-26	FFCP PHASE1:Hg19::chr4:38143865..38143904,-	p@chr4:38143865..38143904, -
3.38e-26	FFCP PHASE2:Hg19::chr4:38143865..38143904,-	p@chr4:38143865..38143904, -
3.9e-25	FFCP PHASE2:Hg19::chr6:14671928..14671958,+	p@chr6:14671928..14671958, +
3.9e-25	FFCP PHASE1:Hg19::chr6:14671928..14671958,+	p@chr6:14671928..14671958, +
5.11e-25	FFCP PHASE2:Hg19::chr2:113982635..113982648,-	p8@PAX8
5.11e-25	FFCP PHASE1:Hg19::chr2:113982635..113982648,-	p8@PAX8
4.16e-24	FFCP PHASE2:Hg19::chr6:18497083..18497107,+	p@chr6:18497083..18497107, +
4.16e-24	FFCP PHASE1:Hg19::chr6:18497083..18497107,+	p@chr6:18497083..18497107, +
6.49e-24	FFCP PHASE2:Hg19::chr5:64469134..64469150,-	p@chr5:64469134..64469150, -
6.49e-24	FFCP PHASE1:Hg19::chr5:64469134..64469150,-	p@chr5:64469134..64469150, -
5.98e-23	FFCP PHASE2:Hg19::chr6:18496965..18496969,+	p@chr6:18496965..18496969, +
5.98e-23	FFCP PHASE1:Hg19::chr6:42724431..42724435,+	p@chr6:42724431..42724435, +
5.98e-23	FFCP PHASE2:Hg19::chr7:20257461..20257472,-	p9@MACC1
5.98e-23	FFCP PHASE1:Hg19::chr6:18496965..18496969,+	p@chr6:18496965..18496969, +
5.98e-23	FFCP PHASE2:Hg19::chr8:101588316..101588317,-	p1@AK127517
5.98e-23	FFCP PHASE2:Hg19::chr16:75511082..75511090,+	p@chr16:75511082..75511090, +
5.98e-23	FFCP PHASE2:Hg19::chr6:42724431..42724435,+	p@chr6:42724431..42724435, +
5.98e-23	FFCP PHASE1:Hg19::chr7:20257461..20257472,-	p9@MACC1
5.98e-23	FFCP PHASE1:Hg19::chr8:101588316..101588317,-	p1@AK127517
5.98e-23	FFCP PHASE1:Hg19::chr16:75511082..75511090,+	p@chr16:75511082..75511090, +
1.52e-22	FFCP PHASE2:Hg19::chr5:73109313..73109326,+	p4@RGNEF
1.52e-22	FFCP PHASE1:Hg19::chr5:73109313..73109326,+	p4@RGNEF
5.58e-22	FFCP PHASE2:Hg19::chr2:162931138..162931149,-	p14@DPP4
5.58e-22	FFCP PHASE1:Hg19::chr2:162931138..162931149,-	p14@DPP4
5.86e-22	FFCP PHASE2:Hg19::chr12:127762515..127762539,-	p@chr12:127762515..127762539, -
5.86e-22	FFCP PHASE1:Hg19::chr12:127762515..127762539,-	p@chr12:127762515..127762539, -
7.34e-22	FFCP PHASE2:Hg19::chr9:83566735..83566738,+	p@chr9:83566735..83566738, +
7.34e-22	FFCP PHASE1:Hg19::chr9:83566735..83566738,+	p@chr9:83566735..83566738, +
8.77e-22	FFCP PHASE2:Hg19::chr20:6034672..6034714,-	p2@LRRN4
8.77e-22	FFCP PHASE1:Hg19::chr20:6034672..6034714,-	p2@LRRN4
9.15e-22	FFCP PHASE2:Hg19::chr13:38083855..38083873,+	p@chr13:38083855..38083873, +
9.15e-22	FFCP PHASE1:Hg19::chr13:38083855..38083873,+	p@chr13:38083855..38083873, +
4.75e-21	FFCP PHASE2:Hg19::chr2:113982348..113982371,-	p@chr2:113982348..113982371, -
4.75e-21	FFCP PHASE1:Hg19::chr2:113982348..113982371,-	p@chr2:113982348..113982371, -
6.42e-21	FFCP PHASE2:Hg19::chr3:197639921..197639934,-	p6@IQCG
6.42e-21	FFCP PHASE1:Hg19::chr3:197639921..197639934,-	p6@IQCG
6.46e-21	FFCP PHASE2:Hg19::chr10:28367236..28367266,+	p@chr10:28367236..28367266, +
6.46e-21	FFCP PHASE1:Hg19::chr10:28367236..28367266,+	p@chr10:28367236..28367266, +
1.04e-20	FFCP PHASE1:Hg19::chr22:30640029..30640037,-	p@chr22:30640029..30640037, -
1.04e-20	FFCP PHASE2:Hg19::chr22:30640029..30640037,-	p@chr22:30640029..30640037, -
1.48e-20	FFCP PHASE1:Hg19::chr22:28901919..28901924,+	p@chr22:28901919..28901924, +
1.48e-20	FFCP PHASE1:Hg19::chr7:17409475..17409478,-	p@chr7:17409475..17409478, -
1.48e-20	FFCP PHASE2:Hg19::chr22:28901919..28901924,+	p@chr22:28901919..28901924, +
1.48e-20	FFCP PHASE2:Hg19::chr7:17409475..17409478,-	p@chr7:17409475..17409478, -
1.54e-20	FFCP PHASE1:Hg19::chr17:57841314..57841323,-	p@chr17:57841314..57841323, -
1.54e-20	FFCP PHASE2:Hg19::chr17:57841314..57841323,-	p@chr17:57841314..57841323, -
3.67e-20	FFCP PHASE1:Hg19::chr9:6257148..6257157,+	p@chr9:6257148..6257157, +
3.67e-20	FFCP PHASE2:Hg19::chr9:6257148..6257157,+	p@chr9:6257148..6257157, +
3.9e-20	FFCP PHASE1:Hg19::chr16:34980881..34980902,+	p1@ENST00000516136
3.9e-20	FFCP PHASE2:Hg19::chr16:34980938..34980966,+	p1@FLJ26245
3.9e-20	FFCP PHASE1:Hg19::chr16:34980938..34980966,+	p1@FLJ26245
3.9e-20	FFCP PHASE2:Hg19::chr16:34980881..34980902,+	p1@ENST00000516136
4.2e-20	FFCP PHASE2:Hg19::chr9:118435168..118435186,+	p@chr9:118435168..118435186, +
4.2e-20	FFCP PHASE1:Hg19::chr9:118435168..118435186,+	p@chr9:118435168..118435186, +
7.09e-20	FFCP PHASE2:Hg19::chr2:113990903..113990907,-	p@chr2:113990903..113990907, -
7.09e-20	FFCP PHASE1:Hg19::chr2:113990903..113990907,-	p@chr2:113990903..113990907, -
8.46e-20	FFCP PHASE2:Hg19::chr10:4284210..4284228,+	p@chr10:4284210..4284228, +
8.46e-20	FFCP PHASE1:Hg19::chr10:4284210..4284228,+	p@chr10:4284210..4284228, +
1.04e-19	FFCP PHASE1:Hg19::chr8:38008450..38008459,-	p4@STAR
1.04e-19	FFCP PHASE2:Hg19::chr8:38008450..38008459,-	p4@STAR
1.89e-19	FFCP PHASE2:Hg19::chr9:5621474..5621483,-	p@chr9:5621474..5621483, -
1.89e-19	FFCP PHASE1:Hg19::chr9:5621474..5621483,-	p@chr9:5621474..5621483, -
2.1e-19	FFCP PHASE2:Hg19::chr2:114036488..114036504,-	p1@PAX8
2.1e-19	FFCP PHASE1:Hg19::chr2:114036488..114036504,-	p1@PAX8
4.93e-19	FFCP PHASE1:Hg19::chr2:1048832..1048860,+	p@chr2:1048832..1048860, +
4.93e-19	FFCP PHASE2:Hg19::chr2:1048832..1048860,+	p@chr2:1048832..1048860, +

Showing 1 to 100 of 100 entries

@@ Line 12: / Line 12: @@
 |is_obsolete=
 |located_in=
-|name=female reproductve organ cancer
+|name=female reproductive organ cancer
-|namespace=disease_ontology
+|namespace=FANTOM
 |obo_creation_date=
 |part_of=

Personal tools

DOID:120: Difference between revisions - resource_browser

Search

Human

Mouse

Rat

Dog

Chicken

Macaque

Cross species

Other

Tools

DOID:120: Difference between revisions

From FANTOM5_SSTAR

Latest revision as of 16:48, 12 September 2014

Ontology Tree: Loaded from BioPortal

FF samples

	FAQ
	Mozilla Cavendish skin modified by DaSch for the Web Community Wiki GitHub project page – Report a bug – Skin version: 2.6.0